У нас вы можете посмотреть бесплатно Thyroid Cancer Disappears WITHOUT SURGERY: Dr. Emad Kandil from Tulane University или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Dr. Emad Kandil, one of the leading thyroid surgeons in the U.S. and a pioneer in non-surgical thyroid cancer treatment, is featured in this video discussing the benefits of thyroid ablation as an alternative to surgery. #thyroidnodule #thyroidcancer #thyroidsurgery Book a phone consultation with a thyroid ablation doctor today! Avoid surgery. No scars. Treat thyroid cancer, goiter, and nodules without surgery: https://www.rfamd.com/patient-booking/ Find a thyroid ablation doctor at: www.rfamd.com About Philip James / philipjames360 / philipb07 / philip-james Philip hosts the Doctor Thyroid podcast, providing patients with the best available information on alternative thyroid treatments. His work focuses on minimally invasive procedures such as thyroid ablation and active surveillance. He aims to help patients avoid unnecessary thyroid surgeries, a mission close to him after his own experience with an unnecessary thyroid surgery. @DoctorThyroid www.docthyroid.com Based at Tulane University, Dr. Kandil has successfully treated numerous patients using this minimally invasive procedure, which allows for the targeted destruction of cancerous thyroid nodules without removing the thyroid gland. 00:01 - 08:03 The patient story told by Vanessa: "you have thyroid cancer" 08:04 - 12:38 Dr. Kandil discusses treating thyroid cancer without surgery In this case, Dr. Kandil treated Vanessa, who was initially diagnosed with a 1.5 cm thyroid nodule and advised by her first doctor to undergo a total thyroidectomy. Concerned about the lifelong consequences of surgery, including the need for thyroid hormone replacement, Vanessa sought out Dr. Kandil, who recommended thyroid ablation. 🛑 Three months after the procedure, her follow-up ultrasound revealed no detectable cancer, highlighting the effectiveness of ablation. The video thoroughly discusses the thyroid ablation process, including Dr. Kandil’s patient-centered approach, the technical aspects of the procedure, and the post-ablation outcomes. Thyroid ablation is a promising option for patients with small, early-stage thyroid cancers who wish to avoid surgery and its associated complications. Dr. Kandil shares insights into why ablation may be a preferred treatment for preserving the thyroid while achieving cancer-free results. Key points covered: 🔹 Dr. Kandil’s expertise in thyroid ablation and patient care 🔹 The non-surgical alternative for treating thyroid cancer 🔹 Patient outcomes following thyroid ablation 🔹 Comparison of thyroidectomy and ablation techniques This video is intended for viewers seeking an evidence-based understanding of thyroid ablation as a viable alternative to surgery. About Dr. Emad Kandil Dr. Emad Kandil is a renowned expert in endocrine and oncological surgery. He is the Chief of General, Endocrine, and Oncological Surgery at Tulane University in New Orleans, Louisiana. He holds the prestigious Elias Hanna Chair in Surgery and is celebrated for his groundbreaking work in minimally invasive thyroid treatments, including thyroid ablation. Dr. Kandil has performed over 1,000 thyroid ablation procedures, establishing himself as a leading figure in using this innovative treatment approach in the United States. Dr. Kandil’s commitment to advancing thyroid care focuses on offering patients non-surgical alternatives, such as ablation, to avoid traditional surgery. This allows for reduced recovery times and better preservation of thyroid function. His contributions to the field include over 400 research publications and numerous lectures worldwide. His research interests include endocrine tumor genetics and the development of targeted therapies for thyroid cancer.